Topic: Viagra
An advisory panel for the US Food and Drug Administration Friday voted unanimously against approving a pill that helps boost women's sex drive, described by some as the "female Viagra." The FDA's Reproductive Health Drugs Advisory Committee said the evidence presented had ...
GAITHERSBURG, Maryland (Reuters) - A pink pill that acts on brain chemicals has helped women with low sex drive, its German manufacturer said on Friday, arguing for the first U.S. approval of a drug to boost women's libido. Officials of privately held ...
WASHINGTON (Reuters) - A pink pill designed to offer women a counterpart to Viagra failed to boost female sex drive in two studies, U.S. drug reviewers said in documents released on Wednesday. Women who took Boehringer Ingelheim's experimental drug flibanserin also reported ...
FDA scientists says the first pill designed to increase female libido failed in 2 studiesUNSTIMULATING RESPONSE: The Food and Drug Administration says a drug from Boehringer Ingelheim designed to stimulate female libido fell short in two studies. PINK PILL: The drug flibanserin ...
WASHINGTON (Reuters) - A pill designed to offer women a counterpart to Viagra failed to boost female sex drive in two studies, U.S. drug reviewers said in documents released on Wednesday. Women who took Boehringer Ingelheim's experimental drug flibanserin also reported depression, ...
Federal health experts meet this week to review the first pill designed to boost the female sex drive, more than a decade after Pfizer's drug Viagra sparked the search for a female counterpart. But even if the drug from Boehringer Ingelheim wins ...
Brazil's top appeals court has ruled that the patent on Viagra expires next month in the South American nation, a year earlier than argued by the manufacturer. That means other companies can begin making generic versions of the erectile dysfunction drug in ...
WASHINGTON (Reuters) - Men with heart disease who also complain of erectile dysfunction die sooner than other male heart patients, researchers reported on Monday. They found that men who had both conditions were twice as likely to die from any cause and ...
Biotech firm Vivus unveiled a would-be player Monday in the 3.7-billion-dollar erectile dysfunction market: avanafil, effective in just 15 minutes, far faster than blockbuster rivals Viagra and Cialis. "The magnitude of success in the first 15 minutes was surprising," Leland Wilson, the ...
A drug that failed to fight the blues could be the female answer to the little blue pill Viagra, the lead North American investigator analysing tests of the drug said Tuesday. Women who took the drug flibanserin when it was being tested ...
